Moneycontrol PRO
HomeNewsSharon bio medicine

Sharon Bio Medicine

Jump to
  • Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y

  • Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y

  • Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y

  • Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y

  • Sharon Bio Medi Standalone December 2020 Net Sales at Rs 45.24 crore, up 15.15% Y-o-Y

  • Sharon Bio Medi Standalone March 2020 Net Sales at Rs 45.79 crore, up 14.12% Y-o-Y

  • Sharon Bio Medi Standalone March 2019 Net Sales at Rs 40.13 crore, up 14.54% Y-o-Y

  • Sharon Bio Medi Standalone September 2018 Net Sales at Rs 39.18 crore, up 25.53% Y-o-Y

  • Sharon Bio Medicine surges 18% after UK drug regulator clears Dehradun unit

    CNBC-TV18 reports quoting Cogencis said the UK drug regulator The Medicines and Healthcare products Regulatory Agency has cleared company's Dehradun unit.

  • Stocks in news: SBI, M&M, Sun Pharma, Wockhardt, TeamLease, PVR

    SBI | Mahindra & Mahindra | Sun Pharma | Tata Motors | Mahindra Lifespaces | PVR | ONGC | Jain Irrigation | Gujarat Alkalies | Ashapura Minechem | Gujarat Narmada | Wockhardt | TeamLease | Andrew Yule | Finolex Cables | Shreyas Shipping and Thermax are stocks, which are in the news today.

  • Sharon Bio-Medicine gets USFDA nod for API plant in Taloja

    The company, however, said it cannot start supplying to the US market as its payment for generic drug user fee is pending.

  • Sharon Bio up 20% on USFDA approval for API plant in Maharashtra

    Sharon Bio Medicine shares were locked at 20 percent upper circuit at Rs 10.16 on Tuesday after the company received approval from the US health regulator for its plant based in Maharashtra.

  • Stocks in news: Grasim, AB Nuvo, SBI, Prime Focus, Sharon, Alkem

    Grasim Industries | Aditya Birla Nuvo | SBI | Prime Focus | Sharon Bio Medicine | Alkem Laboratories | JK Lakshmi Cement | Hero Motocorp | Gitanjali Gems | SP Apparels | DHFL | Sunil Healthcare | Rane Engine Valve | Bharat Financial Inclusion | NLC India | Coffee Day and Trent are stocks, which are in the news today.

  • Top buzzing midcap stocks to trade on June 22

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Dr Reddys Laboratories, Thomas Cook, Max Ventures, GHCL, Hexaware Technologies, Sharon Bio-Medicine, OnMobile, Escorts, Scanpoint Geomatics, Force Motors & Tech Mahindra.

  • Sharon Bio locked at 20% upper circuit post board meeting

    The company at its meeting held on June 21, 2016, has discussed the current financial position of the company and decided to introduce more profitable products.

  • Stocks in news: ITC, Max Ventures, Future Cons, Tech Mah, BASF

    ITC | SBI | Maruti Suzuki | Tech Mahindra | BASF | Future Consumer | Grasim Industries | JSPL | Max Ventures | SKS Microfinance | Majesco | Bayer Cropscience | United Breweries Holdings | Bajaj Finance | Sobha | Shrenuj & Company | Sharon Bio Medicine and Asian Paints are stocks, which are in the news today.

  • Sharon Bio Medi consolidated Dec '15 sales at Rs 104.69 crore

    Sharon Bio Medicine has reported a consolidated total income from operations of Rs 104.69 crore and a net loss of Rs 70.74 crore for the quarter ended Dec '15

  • Stocks in news: BoB, BPCL, IDBI, Future Retail, Dr Lal, Clariant

    Larsen and Toubro | Infosys | Bank of Baroda | IOC | HPCL | BPCL | IDBI Bank | Nestle India | Parsvnath Developers | Future Retail | Punj Lloyd | UCO Bank | Alok Industries | Oil India | McNally Bharat | Dr Lal Pathlabs | NMDC | Puravankara | Clariant Chemicals | Dhanlaxmi Bank | Corporation Bank and Sun TV are stocks, which are in the news today.

  • Sharon Bio Medicine to shut down UAE subsidiary, stock down 15%

    "Board of directors on Tuesday have discussed the closure of subsidiary company Yusur International FZE, based in UAE," says the Mumbai-based pharma company in its filing.

  • Stocks in news: TCS, Sun Pharma, UltraTech, Godfrey, GMR, GVK

    TCS | Sun Pharma | Ultratech Cement | IVRCL | Tata Power | Godfrey Phillips | Bajaj Corp | Deep Industries | Crompton Greaves | GMR Infrastructure | GVK Power | Sharon Bio | Archidply Industries | Reliance Infrastructure | DCB Bank and Vedanta are stocks, which are in the news today.

  • Stocks in news: RComm, Wipro, Union Bank, Sharon Bio, GIC Hsg

    Wipro | Reliance Communications | Union Bank | Lanco Infratech | Amtek Auto | GIC Housing Finance | Monnet Ispat | Shiv Vani Oil | Garden Silk Mills | Container Corporation | Jet Airways | Godrej Consumer | Torrent Pharma | Usha Martin | Sharon Bio and Monnet Ispat are stocks, which are in the news today.

  • Sharon Bio up 6%, R&D dept clears surveillance inspection

    "Sancturary for research and development (SA-FORD), a division of Sharon, had cleared national good laboratory practice (GLP) compliance monitoring authority (NGCMA) surveillance inspection," says the Maharashtra-based pharma company in its filing.

  • Top buzzing midcap stocks to trade on December 11

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have – Deccan Cement, Panyam Cement, KCP, Sagar Cement, Sharon Bio-Medicine, Shilpa Medicare, Nestle India, Apollo Hospital, Fortis Health and Texrail.

  • Maruti, Sharon Bio, Havells, Titan likely to be in focus

    Stocks likely to be in the limelight are: Maruti Suzuki India, Sharon Bio Medicine, Havells India, Texmaco Rail and Engineering, BF Utilities, Titan Company, Narayana Healthcare, Fortis Healthcare, Apollo Hospitals Enterprises, Oil India, Dish TV India.

  • Sharon zooms on USFDA inspection report for Dehradun plant

    US Food and Drug Administration officials have inspected company's Taloja plant and the outcome of inspection is awaited, says the company in its filing to exchanges.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347